The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This brief analyzes current experiences of Medicare beneficiaries ages 65 and older with respect to satisfaction and access measures and examines whether privately-insured adults ages 50 to 64 report access or cost problems at higher or lower rates than Medicare beneficiaries 65 and older.
A new KFF-Los Angeles Times partnership survey of immigrant adults – the largest nationally representative survey focused on immigrants – shows that while most feel they found a better life for their families in this country, many also face economic hardships and discrimination. Conducted in partnership with the Los Angeles Times, the survey of more than 3,300 immigrants conducted in 10 languages captures the varied experiences of immigrants living in the United States today, including…
A new chart collection looks at how internet access may affect health care in the U.S., as more providers turn to telemedicine during the pandemic. An estimated 25 million Americans - about 8% of the population - lack access to internet at home. Hispanic and Black Americans, seniors, rural residents, and those living in poverty are more likely than other groups to lack internet access. The chart collection is available on the Peterson-KFF Health System…
The Medicare Part D program provides an outpatient prescription drug benefit to more than 50 million older adults and people with long-term disabilities in Medicare who enroll in private plans, including stand-alone prescription drug plans (PDPs) to supplement traditional Medicare and Medicare Advantage prescription drug plans (MA-PDs) that include drug coverage and other Medicare-covered benefits. This brief analyzes Medicare Part D enrollment and costs in 2025 and trends over time, based on data from the…
Medicaid represents $1 out of every $5 spent on health care in the U.S. and is the major source of financing for states to provide health coverage and long-term services and supports for low-income residents. This brief examines key questions about Medicaid financing and how it works.
About a third (32%) of the public view racism as a major problem in health care, fewer than say the same about politics (56%), the criminal justice system (54%), and policing (51%), a new KFF report on the public’s views of racism finds. The lower levels of perceived racism in health care may reflect high levels of trust in doctors and health care providers across racial and ethnic groups. Overall, Black adults are much more…
This brief provides an overview of current lawsuits in health policy including preventive services, abortion care, gender affirming care, Medicare drug price negotiations, nursing home staffing rules, private coverage consumer protections, and protections and health coverage for Deferred Action for Childhood Arrivals (DACA) recipients; how they may be affected by the incoming Trump administration; and the implications of their potential outcomes.
Under the Inflation Reduction Act, the federal government for the first time will negotiate directly with drug companies to determine the prices that Medicare will pay for certain high expenditure drugs covered under Medicare Part D (starting in 2026) and Part B (starting in 2028). Part D covers retail prescription drugs and Part B covers physician-administered medications. This new requirement is the culmination of years of debate among lawmakers in Congress, and the Centers for…
KFF surveyed state Medicaid officials about behavioral health policies related to administration, delivery systems, integrated care, and data analytics.
The Centers for Medicare and Medicaid Services has recently taken actions to increase transparency in Medicare Advantage, however substantial data gaps remain that limit the ability of policymakers and researchers to conduct oversight and assess the program's performance, and for Medicare beneficiaries to compare Medicare Advantage plans offered in their area.
© 2026 KFF
